SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-09-003869
Filing Date
2009-05-11
Accepted
2009-05-11 17:04:56
Documents
5
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 PENWEST PHARMACEUTICALS CO. b75203ppe10vq.htm 10-Q 376545
2 EX-10.1 RIGHTS AGREEMENT, DATED AS OF MARCH 11, 2009 b75203ppexv10w1.htm EX-10.1 10199
3 EX-10.2 THIRD AMENDMENT, SIGNED MARCH 31, 2009, TO THE AMENDED AND RESTATED STRA b75203ppexv10w2.htm EX-10.2 22744
4 EX-31 SECTION 302 CERTIFICATION OF CEO & CFO b75203ppexv31.htm EX-31 8149
5 EX-32 SECTION 906 CERTIFICATION OF CEO & CFO b75203ppexv32.htm EX-32 2762
  Complete submission text file 0000950135-09-003869.txt   421842
Mailing Address 39 OLD RIDGEBURY ROAD SUITE 11 DANBURY CT 06810-5120
Business Address 39 OLD RIDGEBURY ROAD SUITE 11 DANBURY CT 06810-5120 877-736-9378
PENWEST PHARMACEUTICALS CO (Filer) CIK: 0001047188 (see all company filings)

IRS No.: 911513032 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34267 | Film No.: 09815986
SIC: 2834 Pharmaceutical Preparations